<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03317912</url>
  </required_header>
  <id_info>
    <org_study_id>ULiege</org_study_id>
    <nct_id>NCT03317912</nct_id>
  </id_info>
  <brief_title>Perioperative Lignocaine and Sleep Disturbance</brief_title>
  <official_title>Effect of Peroperative Intravenous Infusion of Lignocaine on the Quality of Postoperative Sleep</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital of Liege</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital of Liege</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this clinical trial is to study the effect of an intravenous infusion of lidocaïne
      in a multimodal analgesic protocol on the architecture sleep during the first postoperative
      night.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      To study the effect of lidocaïne, we plan to include 40 patients, randomized in 2 groups,
      undergoing open prostate surgery in this randomized placebo-controlled trial.

      Before anesthesia induction, these patients receive an intravenous lidocaine infusion (bolus
      1,5 mg.kg-1 followed by a continuous infusion of 2mg.kg-1.h during 24 hours) or an equal
      volume of placebo. Then the anesthesia is induced with propofol, sufentanil et rocuronium.
      The postoperative analgesia is provided by paracetamol, tramadol and patient-controlled
      analgesia (PCA) with morphine or oral oxycodone. A polysomnography is registred on the
      preoperative night and on the first postoperative night.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">December 2017</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Anticipated">December 2018</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Time ratio between rapid eye movement sleep(REM) + Stage 3 sleep / Stage 1 + Stage 2 sleep</measure>
    <time_frame>Postoperaty day 1</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Sleep latence</measure>
    <time_frame>Postoperaty day 1</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sleep time</measure>
    <time_frame>Postoperaty day 1</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cumulative Opioid use</measure>
    <time_frame>Postoperaty day 1</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of analgesia (Visual Analogic Scale)</measure>
    <time_frame>Postoperaty day 1</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Sleep Disturbance</condition>
  <arm_group>
    <arm_group_label>Lidocaïne 2%</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Bolus 0.075ml/kg/h, following by continuous infusion 0.1ml/kg/h during surgery and 0.066ml/kg/h during 24h</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo (for Lidocaïne)</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Bolus 0.075ml/kg/h, following by continuous infusion 0.1ml/kg/h during surgery and 0.066ml/kg/h during 24h</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Lidocaïne 2%</intervention_name>
    <description>Continuous infusion during per and postoperative periods</description>
    <arm_group_label>Lidocaïne 2%</arm_group_label>
    <other_name>lignocaïne</other_name>
    <other_name>Linisol</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo (for Lidocaïne)</intervention_name>
    <description>Continuous infusion during per and postoperative periods</description>
    <arm_group_label>Placebo (for Lidocaïne)</arm_group_label>
    <other_name>NaCl 0.9%</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Radical prostatectomy

        Exclusion Criteria:

          -  BMI &gt; 30

          -  Neurologic/psychiatric diseases or therapeutics, seizyres

          -  Cardiac disease, second or third degree atrioventricular block

          -  Obstructive sleep apnea syndrome

          -  History of liver or renal insufficiency

          -  and any contraindication to the anesthetic protocol of the study.
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Isabelle Maquoi</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU Liege - Department of Anesthesia and Intensive Care Medicine</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Isabelle Maquoi</last_name>
    <phone>32 4 366 7179</phone>
    <email>i.maquoi@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Gregory Hans</last_name>
    <phone>32 4 366 7179</phone>
  </overall_contact_backup>
  <results_reference>
    <citation>Kaba A, Laurent SR, Detroz BJ, Sessler DI, Durieux ME, Lamy ML, Joris JL. Intravenous lidocaine infusion facilitates acute rehabilitation after laparoscopic colectomy. Anesthesiology. 2007 Jan;106(1):11-8; discussion 5-6.</citation>
    <PMID>17197840</PMID>
  </results_reference>
  <results_reference>
    <citation>Krenk L, Jennum P, Kehlet H. Postoperative sleep disturbances after zolpidem treatment in fast-track hip and knee replacement. J Clin Sleep Med. 2014 Mar 15;10(3):321-6. doi: 10.5664/jcsm.3540.</citation>
    <PMID>24634631</PMID>
  </results_reference>
  <verification_date>October 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 31, 2015</study_first_submitted>
  <study_first_submitted_qc>October 17, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">October 23, 2017</study_first_posted>
  <last_update_submitted>October 17, 2017</last_update_submitted>
  <last_update_submitted_qc>October 17, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">October 23, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Hospital of Liege</investigator_affiliation>
    <investigator_full_name>Jean François Brichant</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dyssomnias</mesh_term>
    <mesh_term>Sleep Wake Disorders</mesh_term>
    <mesh_term>Parasomnias</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lidocaine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

